학술논문
Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry
Document Type
Artikel
Author
Salmanton-García, J; Marchesi, F; Koehler, P; Weinbergerová, B; Čolović, N; Falces-Romero, I; Buquicchio, C; Farina, F; van Praet, J; Biernat, MM; Itri, F; Prezioso, L; Tascini, C; Vena, A; Romano, A; Delia, M; Dávila-Valls, J; Martín-Pérez, S; Lavilla-Rubira, E; Adžić-Vukičević, T; García-Bordallo, D; López-García, A; Criscuolo, M; Petzer, V; Fracchiolla, NS; Espigado, I; Sili, U; Meers, S; Erben, N; Cattaneo, C; Tragiannidis, A; Gavriilaki, E; Schönlein, M; Mitrovic, M; Pantic, N; Merelli, M; Labrador, J; Hernández-Rivas, JÁ; Glenthøj, A; Fouquet, G; Del Principe, MI; Dargenio, M; Calbacho, M; Besson, C; Kohn, M; Gräfe, S; Hersby, DS; Arellano, E; Çolak, GM; Wolf, D; Marchetti, M; Nordlander, A; Blennow, O; Cordoba, R; Mišković, B; Mladenović, M; Bavastro, M; Limongelli, A; Rahimli, L; Pagano, L; Cornely, OA
Source
International journal of antimicrobial agents. 62(4):106952
Subject
Language
English
English
English
ISSN
1872-7913